GB1336895A - 9beta,10alpha-steroids and a process for the manufacture thereof - Google Patents
9beta,10alpha-steroids and a process for the manufacture thereofInfo
- Publication number
- GB1336895A GB1336895A GB1637871A GB1637871A GB1336895A GB 1336895 A GB1336895 A GB 1336895A GB 1637871 A GB1637871 A GB 1637871A GB 1637871 A GB1637871 A GB 1637871A GB 1336895 A GB1336895 A GB 1336895A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- compound
- compounds
- steroids
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1336895 9#,10α-Steroids F HOFFMANNLA ROCHE & CO AG 21 May 1971 [21 May 1970 (2)] 16378/71 Headings C2U and C2C The invention comprises compounds of formula (wherein R is C 2-8 alkyl), and their preparation from compounds of formula (wherein R<SP>1</SP> and R<SP>2</SP> are each H or Me, at least one being Me) by the successive steps of: (i) protecting the two oxo groups (e.g. by ketalization, heteroketalization, or reduction to hydroxyl groups which are then esterified or etherified); (ii) hydrogenation to give a compound of formula (iii) treatment with a strong base to give a compound of formula (iv) regeneration of the free oxo groups; and (v) cyclization of the resulting trione. Steps (iv) and (v) may be effected in a single step when employing a mineral acid. Compounds of Formula II and antecedents thereof are as described in Specifications 1,336,896 and 1,298,212. Pharmaceutical compositions for oral, parenteral, rectal and topical administration comprise a carrier and a compound of Formula I. The type of activity of the latter is not specified.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3956070A | 1970-05-21 | 1970-05-21 | |
CH749870A CH565729A5 (en) | 1970-05-21 | 1970-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1336895A true GB1336895A (en) | 1973-11-14 |
Family
ID=25701459
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1637871A Expired GB1336895A (en) | 1970-05-21 | 1971-05-21 | 9beta,10alpha-steroids and a process for the manufacture thereof |
GB4118272A Expired GB1336896A (en) | 1970-05-21 | 1971-05-21 | Desa-9beta-steroids |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4118272A Expired GB1336896A (en) | 1970-05-21 | 1971-05-21 | Desa-9beta-steroids |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE767348A (en) |
DE (1) | DE2123046A1 (en) |
FR (1) | FR2100671B1 (en) |
GB (2) | GB1336895A (en) |
NL (1) | NL7105885A (en) |
-
1971
- 1971-04-29 NL NL7105885A patent/NL7105885A/xx unknown
- 1971-05-10 DE DE19712123046 patent/DE2123046A1/en active Pending
- 1971-05-19 FR FR7118178A patent/FR2100671B1/fr not_active Expired
- 1971-05-19 BE BE767348A patent/BE767348A/en unknown
- 1971-05-21 GB GB1637871A patent/GB1336895A/en not_active Expired
- 1971-05-21 GB GB4118272A patent/GB1336896A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2100671A1 (en) | 1972-03-24 |
GB1336896A (en) | 1973-11-14 |
NL7105885A (en) | 1971-11-23 |
BE767348A (en) | 1971-11-19 |
DE2123046A1 (en) | 1972-01-27 |
FR2100671B1 (en) | 1974-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1429922A (en) | Steroid acetals processes for their manufacture and preparations containing them | |
GB1351003A (en) | 5-azapyrimidine-nucleosides | |
ATE36859T1 (en) | 4'-DEMETHYL-4-EPIPODOPHYLLOTOXIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS. | |
GB1392275A (en) | Therapeutic compositions | |
GB1507957A (en) | Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them | |
GB1355147A (en) | Oxoprostanoic acid derivatives | |
GB1359542A (en) | Diglycidyl derivatives of n-heterocyclic compounds processes for their production and the use thereof | |
GB1374299A (en) | Derivatives of 1,2,3,4-tetrahydroisoquinoline production of the same and composition thereof | |
IE32453L (en) | Pteridine derivatives | |
IE34812B1 (en) | Evomonoside derivatives | |
GB1336895A (en) | 9beta,10alpha-steroids and a process for the manufacture thereof | |
GB1276812A (en) | Novel aminopiperidines, processes for their preparation, and compositions incorporating them | |
GB1361863A (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
GB1397434A (en) | Evomonoside derivatives | |
GB1373900A (en) | Corticoid ester and method of preparing it | |
IE34590B1 (en) | Phenylethanolamine derivatives | |
IE34826B1 (en) | New derivatives of neriifolin | |
GB1420533A (en) | Pyridine derivatives having juvenile hormone activity | |
GB1268008A (en) | ESTERS OF p-BYPHENYLYLACETIC ACID | |
GB1302494A (en) | ||
GB1327745A (en) | Steroid glycosides and a process for their manufacture | |
GB1353511A (en) | Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity | |
IE34081L (en) | Butanolamines | |
IE37779B1 (en) | New benzopyran derivatives | |
GB1205083A (en) | Improvements in or relating to lineomycin derivatives and the manufacture thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |